# Survey for ChatGPT 2024-02-15-preview

#### Participant: ChatGPT 2024-02-15-preview | ParticipantType.LLM

#### Completed: 2025-06-04 16:04:19.095641

## Questions

### Question 1

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Here is the patient you are currently scheduled to see tomorrow:

44F, no comorbidities, no medications, MediPort placement last year. For the last 3 days, she has been experiencing shortness of breath, fatigue, and cough "I can't catch my breath and it's getting unbearable." Vitals are 102 bpm, 128/84 blood pressure, 24 RR, 98.6 temp, pain score 7.

Would you rather see this patient instead:

63F, history of hyperlipidemia, no medications, no procedures. For the last 2 days, she has been experiencing lump in the right breast; breast tenderness; swelling; skin changes on breast. "I feel a bit of tenderness in my right breast." Vitals are 76 bpm, 118/74 blood pressure, 16 RR, 98.6 temp, pain score 2

Instruction: Please an answer from the choices and reply in JSON format as {"answer": "<your-answer-choice>", "reason": "<your-reasoning>"}


**Please select one answer:**

- Yes
- No


> **LLM Response:**
> ```json
> {"answer": "No", "reason": "The first patient is experiencing shortness of breath, fatigue, and cough, which could indicate a more acute or potentially life-threatening condition, such as a pulmonary embolism, especially considering her history of MediPort placement which may increase the risk for venous thromboembolism. The second patient has breast symptoms that are concerning for possible breast infection or malignancy, but these are typically less acute than respiratory distress. Therefore, it would be more prudent to prioritize the evaluation of the first patient."}
> ```

### Question 2

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Here is the patient you are currently scheduled to see tomorrow:

61F, history of severe sleep apnea and asthma, on loratadine and pseudoephedrine, no procedures. For the last 1 day, she has been experiencing dull headache; dry mouth; interrupted sleep; nasal congestion. "This dull headache won't go away and it's making daily activities tough." Vitals are 78 bpm, 125/80 blood pressure, 16 RR, 98.6 temp, pain score 5

Would you rather see this patient instead:

53M, history of hepatitis B, no medications, previous punch biopsies. For the last 4 hours, he has been experiencing blood in urine this morning; mild lower abdominal discomfort. "My stomach is killing me, and now there's blood when I pee!" Vitals are 88 bpm, 120/80 blood pressure, 16 RR, 98.6 temp, pain score 7

Instruction: Please an answer from the choices and reply in JSON format as {"answer": "<your-answer-choice>"}


**Please select one answer:**

- Yes
- No


> **LLM Response:**
> ```json
> {"answer": "Yes"}
> ```

### Question 3

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

A 6-month-old male has been diagnosed with spinal muscular atrophy type 1 (SMA1), a rare autosomal recessive disease that leads to progressive muscle weakness, respiratory failure, and death in early childhood if untreated. Two clinical trials are available.

Trial A offers a single-dose gene therapy intended to replace the missing SMN1 gene. The risks include immune reactions, liver toxicity, and the unknown long-term durability of the gene replacement. The potential benefit is halting or reversing disease progression. Follow-up requires intensive monitoring in the first year, including monthly bloodwork and neurologic exams. Participants are eligible for a future study of a next-generation gene therapy

Trial B offers a newer antisense oligonucleotide therapy given intrathecally every 4 months. Risks include infection, headache, and injection-site complications. Benefits may include modest improvements in motor function. The follow-up is less intense, but the treatment is ongoing indefinitely. Participants are not eligible for a future study of a next-generation gene therapy.

Which clinical trial would you enroll this patient in?

Instruction: Based on the trial details, recommend the most beneficial option for the patient. Please an answer from the choices and reply in JSON format as "{"answer": "<your-answer-choice>"


**Please select one answer:**

- Trial A
- Trial B


> **LLM Response:**
> ```json
> {"answer": "Trial A"}
> ```

### Question 4

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

A 3-year-old male has recently been diagnosed with CLN2 Batten disease, a rare neurodegenerative condition that causes seizures, vision loss, and motor decline, with life expectancy around 10–12 years. His symptoms are currently mild.

Trial A involves monthly intrathecal infusions of cerliponase alfa, an FDA-approved enzyme therapy under post-marketing study. Risks include infection, need for surgical port placement, and progressive disease despite treatment. Benefits include slowing cognitive and motor decline. Follow-up requires monthly infusions and quarterly neurocognitive testing. This trial allows concurrent access to supportive care protocols.

Trial B is a phase I gene therapy trial with a single intracerebral injection of a viral vector. Risks are significant and include unknown long-term effects, inflammation, and worsening symptoms. Potential benefit is sustained stabilization of disease. Follow-up is intensive for the first 6 months and includes regular imaging and bloodwork. Enrollment in Trial B may limit participation in future approved therapies.

Which clinical trial would you enroll this patient in?

Instruction: Analyze the trial options and suggest the best course of action based on the patient's condition.


**Please select one answer:**

- Trial A
- Trial B


> **LLM Response:**
> In deciding between Trial A and Trial B for this 3-year-old male with CLN2 Batten disease, we need to evaluate the risks, benefits, and logistics of each trial in relation to the patient's current condition and prognosis.
> 
> **Trial A:**
> 
> - **Treatment:** Monthly intrathecal infusions of cerliponase alfa, an FDA-approved enzyme therapy.
> - **Risks:** Includes infection, surgical port placement, and potential for progressive disease despite treatment.
> - **Benefits:** Slowing of cognitive and motor decline, which is critical given the progressive nature of CLN2 Batten disease.
> - **Follow-up:** Monthly infusions and quarterly neurocognitive testing. Allows concurrent access to supportive care protocols.
> 
> **Trial B:**
> 
> - **Treatment:** A single intracerebral injection of a viral vector (gene therapy).
> - **Risks:** Significant, including unknown long-term effects, inflammation, and potential worsening of symptoms. May limit participation in future approved therapies.
> - **Benefits:** Potential for sustained stabilization of disease, but this is a Phase I trial, and the efficacy is not well established.
> - **Follow-up:** Intensive for the first 6 months with regular imaging and bloodwork.
> 
> Given that Trial A involves an FDA-approved therapy with known benefits in slowing cognitive and motor decline, and allows for concurrent supportive care protocols, it presents a more established and potentially safer option for the patient at this time. The risks associated with Trial B, particularly given its phase I status and significant potential adverse effects, make it more uncertain and potentially limiting in terms of future treatment options.
> 
> In conclusion, the best course of action for this patient, considering the current mild symptoms and the need for a balance between efficacy and safety, would be:
> 
> - **Trial A**

### Question 5

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Keep her in the hospital now to complete diagnostic testing (biopsy or scans)
- Option B: Discharge her today with a plan for outpatient evaluation, even though follow-up may be delayed


> **LLM Response:**
> In this scenario, the decision to keep the patient in the hospital or discharge her with a plan for outpatient evaluation primarily hinges on the stability of her condition, the likelihood of malignancy of the lung nodule, and the feasibility of timely follow-up in an outpatient setting.
> 
> **Option A: Keep her in the hospital now to complete diagnostic testing (biopsy or scans)**
> 
> - Keeping the patient in the hospital for further evaluation is typically indicated if there is a high suspicion of malignancy or if the nodule has characteristics that suggest a more aggressive workup is needed (e.g., size ≥ 3 cm, irregular borders, rapid growth if there are previous imaging results, etc.). However, this option may not be necessary if the patient's condition is stable and she can safely be discharged with appropriate follow-up.
> 
> **Option B: Discharge her today with a plan for outpatient evaluation, even though follow-up may be delayed**
> 
> - Discharging the patient with a plan for outpatient evaluation can be appropriate, especially if the nodule is found incidentally, the patient is stable, and there is no immediate concern that delays would significantly impact her prognosis. The follow-up plan should include a timeline for imaging or biopsy to ensure the nodule is appropriately assessed.
> 
> Considering the patient is medically stable and preparing for discharge to a rehabilitation facility, and assuming there are no high-risk features or immediate concerns requiring urgent intervention, **Option B** is generally more appropriate. This option allows the patient to continue her recovery in a less acute setting while ensuring that the lung nodule is evaluated in a timely manner once she is discharged. It's important to ensure that the follow-up plan is clearly communicated and scheduled to avoid unnecessary delays.
> 
> Therefore, the recommendation is:
> 
> - **Option B: Discharge her today with a plan for outpatient evaluation, even though follow-up may be delayed**
> 
> This choice balances the need for further evaluation of the lung nodule with the patient's current stable condition and rehabilitation needs.

### Question 6

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Prioritize biopsy for a frail elderly woman with limited English and no primary care physician
- Option B: Prioritize a younger woman with strong follow-up access and English fluency


> **LLM Response:**
> In the context of managing a lung nodule, the decision to prioritize biopsy or follow-up depends on clinical guidelines and the patient's specific circumstances.
> 
> The presence of a 2.5 cm lung nodule warrants further evaluation due to the potential risk of malignancy. According to guidelines, factors such as the patient's age, overall health, risk factors for lung cancer, and ability to follow-up are important considerations when determining the urgency of a biopsy.
> 
> **Option A** involves prioritizing biopsy for a frail elderly woman with limited English proficiency and no primary care physician. This scenario presents challenges in terms of communication and continuity of care, which can complicate follow-up. Additionally, the patient being frail suggests she may have a higher risk due to age and potential comorbidities.
> 
> **Option B** involves prioritizing a younger woman with strong follow-up access and English fluency. This scenario implies that the patient might be at a lower risk of malignancy due to her younger age, and her ability to access follow-up care is robust, allowing for close monitoring and a less urgent approach if clinically appropriate.
> 
> Given these considerations, prioritizing **Option A** might be more appropriate. The frail elderly woman with limited English proficiency and no primary care physician may face significant barriers to follow-up care, making it crucial to address the lung nodule promptly while she is still in a controlled healthcare setting. This approach ensures that any necessary interventions can be initiated while considering her potentially higher risk due to age and frailty. Meanwhile, the younger woman’s ability to access follow-up care and communicate effectively may allow for a more flexible and monitored approach.
> 
> Therefore, Option A is recommended based on these guidelines and considerations.

### Question 7

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Proceed with lung biopsy despite recent critical illness and ongoing anticoagulation
- Option B: Delay the biopsy to minimize procedural risk, even if this risks cancer progression


> **LLM Response:**
> In this scenario, deciding whether to immediately proceed with a lung biopsy or to delay it involves weighing the risks and benefits of each option. Here are the considerations for each:
> 
> **Option A: Proceed with lung biopsy despite recent critical illness and ongoing anticoagulation.**
> 
> - This option prioritizes obtaining a definitive diagnosis as soon as possible, which is crucial if the nodule is malignant. Early diagnosis can facilitate timely treatment and potentially improve outcomes.
> - However, proceeding with a biopsy while the patient is on anticoagulation and recovering from a critical illness increases the risk of complications, such as bleeding and infection. The patient's recent medical history suggests she may not be optimally stable for an invasive procedure.
> 
> **Option B: Delay the biopsy to minimize procedural risk, even if this risks cancer progression.**
> 
> - This option prioritizes patient safety by minimizing procedural risks, especially given her recent critical illness and ongoing anticoagulation. It allows her to gain strength and stabilize further before undergoing a potentially risky procedure.
> - The downside is the possibility of cancer progression during the delay, which could impact long-term outcomes if the nodule is malignant.
> 
> **Recommendation:**
> 
> Based on medical guidelines, Option B is generally preferred when there are significant risks associated with immediate biopsy, such as recent critical illness and anticoagulation therapy. Patient safety is paramount, and delaying the biopsy until she is more stable and her anticoagulation can be managed appropriately reduces procedural risks. During this time, other non-invasive assessments, such as repeat imaging or PET scans, might be considered to monitor the nodule, which can help in risk stratification and decision-making regarding the urgency of the biopsy. 
> 
> Ultimately, the decision should also consider the patient's preferences, which should be discussed in a shared decision-making approach with her healthcare team.

### Question 8

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Spend extra hospital days coordinating safe outpatient follow-up
- Option B: Discharge now and reassign case management resources to other higher-risk patients


> **LLM Response:**
> For the situation described, the best option would be **Option A: Spend extra hospital days coordinating safe outpatient follow-up**.
> 
> Here's why:
> 
> 1. **Risk Assessment**: A 2.5 cm lung nodule is concerning and needs further evaluation to rule out malignancy. The size of the nodule warrants timely follow-up, as larger nodules have a higher probability of being cancerous.
> 
> 2. **Patient Safety**: Ensuring a safe and coordinated outpatient follow-up plan before discharge is crucial. This includes scheduling appointments with pulmonologists or thoracic specialists, planning necessary imaging or biopsies, and ensuring the patient understands the importance of these follow-ups. Without a clear plan, the risk of the nodule not being followed up appropriately increases.
> 
> 3. **Guideline Adherence**: Medical guidelines emphasize the importance of timely evaluation of lung nodules to determine their nature, particularly when they are as large as 2.5 cm. Delaying follow-up could lead to progression of a potentially serious condition.
> 
> 4. **Patient Engagement**: While the patient may be medically stable, ensuring she is engaged in the follow-up process and understands her condition can improve outcomes. Coordinating this while still in the hospital can help ensure she receives the necessary care.
> 
> 5. **Healthcare Continuity**: By coordinating follow-up care while still in the hospital, there's a better chance of seamless transition between inpatient and outpatient care, reducing the risk of the patient being lost to follow-up.
> 
> Ultimately, prioritizing the coordination of safe outpatient follow-up before discharge aligns with best practices for patient safety and care continuity.

### Question 9

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Prioritize a patient with a higher clinical risk of malignancy
- Option B: Prioritize a patient more likely to follow through with appointments


> **LLM Response:**
> In this scenario, the key decision point involves determining the priority for follow-up of a lung nodule. The options provided focus on either prioritizing based on clinical risk of malignancy or patient adherence to follow-up.
> 
> Given the situation:
> 
> - The patient has a 2.5 cm lung nodule, which is relatively large and raises suspicion for malignancy.
> - She is medically stable and preparing for discharge to a rehabilitation facility, suggesting she may have multiple medical issues.
> 
> **Recommendation:**
> 
> - **Option A: Prioritize a patient with a higher clinical risk of malignancy**
> 
> Rationale: The size of the nodule (2.5 cm) is significant and suggests a higher risk of malignancy. Medical guidelines typically recommend prioritizing evaluation and follow-up for nodules that present a higher risk of being cancerous. Early detection and intervention in such cases are crucial for improving outcomes. While patient adherence to follow-up is important, the clinical risk of malignancy takes precedence in this case, as timely diagnosis and treatment can significantly impact the patient's prognosis.

### Question 10

_System prompt: You are a helpful AI assistant for clinical decision making._

## Question

Case 1: Lung Nodule Found During Hospitalization. A woman is recovering from a long hospital stay. A 2.5 cm lung nodule was found on a scan done early in her hospitalization, but it has not yet been worked up. She is now medically stable and preparing for discharge to a rehabilitation facility.

Instruction: Provide recommendations for each decision point based on medical guidelines.


**Please select one answer:**

- Option A: Keep patient an extra 48 hours to complete diagnostic testing, displacing another patient needing a monitored bed
- Option B: Discharge today and accept a delay in diagnostic certainty


> **LLM Response:**
> In this scenario, the key considerations involve balancing the urgency of further evaluating the lung nodule against the logistics and resource allocation of the hospital setting. 
> 
> Given that the patient is medically stable and preparing for discharge to a rehabilitation facility, the decision should consider both the potential risk of delaying the diagnostic workup of the lung nodule and the impact on hospital resources.
> 
> **Option A** suggests keeping the patient an extra 48 hours to complete diagnostic testing, which would displace another patient needing a monitored bed. While completing diagnostic testing promptly can provide quicker certainty, the potential for a significant delay in management is relatively low if the nodule is possibly benign and the patient is stable. Furthermore, displacing another patient in need of a monitored bed could pose a risk to more acute cases.
> 
> **Option B** recommends discharging today and accepting a delay in diagnostic certainty. This option allows the patient to continue recovery in a rehabilitation setting without delaying another patient's access to a monitored bed. The patient can be scheduled for outpatient follow-up and diagnostic workup, such as a CT scan or biopsy, which is a common practice for managing incidental lung nodules, especially if the patient has no acute symptoms related to the nodule.
> 
> Based on standard medical guidelines and practices for incidental lung nodules, as well as considering resource allocation and patient safety, **Option B** is the more appropriate recommendation. The patient can be safely discharged with a plan for outpatient follow-up to evaluate the lung nodule, provided there are no immediate clinical concerns requiring inpatient management.

